<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6213772\results\search\disease\results.xml">
  <result pre="Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Live attenuated" exact="influenza" post="vaccines (LAIV) have prevented morbidity and mortality associated with"/>
  <result pre="influenza vaccines (LAIV) have prevented morbidity and mortality associated with" exact="influenza" post="viral infections for many years and represent the best"/>
  <result pre="years and represent the best therapeutic option to protect against" exact="influenza" post="viral infections in humans. However, the development of LAIV"/>
  <result pre="to be a highly appropriate option for the treatment of" exact="influenza" post="viral infections. For that, the viral RNA synthesis machinery"/>
  <result pre="In this review, we discuss the potential to manipulate the" exact="influenza" post="viral RNA-dependent RNA polymerase (RdRp) complex to generate attenuated"/>
  <result pre="that can be used as LAIV for the treatment of" exact="influenza" post="viral infections, one of the current and most effective"/>
  <result pre="current and most effective prophylactic options for the control of" exact="influenza" post="in humans. influenza virus influenza vaccine live-attenuated influenza virus"/>
  <result pre="effective prophylactic options for the control of influenza in humans." exact="influenza" post="virus influenza vaccine live-attenuated influenza virus recombinant influenza virus"/>
  <result pre="options for the control of influenza in humans. influenza virus" exact="influenza" post="vaccine live-attenuated influenza virus recombinant influenza virus viral polymerase"/>
  <result pre="control of influenza in humans. influenza virus influenza vaccine live-attenuated" exact="influenza" post="virus recombinant influenza virus viral polymerase complex nucleoprotein temperature-sensitive"/>
  <result pre="in humans. influenza virus influenza vaccine live-attenuated influenza virus recombinant" exact="influenza" post="virus viral polymerase complex nucleoprotein temperature-sensitive cold-adapted attenuated 1."/>
  <result pre="are the causative agents of influenza. There are four recognized" exact="influenza" post="types denoted as A, B, C, and the recently"/>
  <result pre="in the absence of pre-existing immunity in humans. In contrast," exact="influenza" post="B viruses (IBV) are mainly restricted and adapted to"/>
  <result pre="thought to cause epidemics or pandemics [12,13]. The newly identified" exact="influenza" post="D viruses (IDV) primarily affect cattle and pigs and,"/>
  <result pre="infections represent a serious public health problem that cause contagious" exact="respiratory disease" post="and substantial morbidity and mortality in humans, resulting in"/>
  <result pre="introduced into the human population [23]. For instance, the first" exact="influenza" post="pandemic of the 21st century was declared in 2009"/>
  <result pre="These two lineages diverged in the 1980s from the ancestral" exact="influenza" post="B/Lee/40. Although perceived as less dangerous than IAV, IBV"/>
  <result pre="IAV to modify their genome and their rapid transmission, seasonal" exact="influenza" post="vaccines need to be reformulated annually to ensure that"/>
  <result pre="important human virus are highly desirable [34,35]. Despite countermeasures against" exact="influenza" post="that prevent (vaccines) or treat (antivirals) viral infections, this"/>
  <result pre="data from the World Health Organization (WHO) estimate that seasonal" exact="influenza" post="virus infections are responsible of about 3–5 million cases"/>
  <result pre="deaths worldwide yearly [36] (http://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)). Current available options to counter" exact="influenza" post="infections include both vaccines and antivirals. Vaccines are the"/>
  <result pre="immunity, and they are the primary prophylactic means to prevent" exact="influenza" post="viral infections [35,37,38]. The first vaccine option is the"/>
  <result pre="infections [35,37,38]. The first vaccine option is the chemically inactivated" exact="influenza" post="vaccine (IIV), which requires a large quantity of virus"/>
  <result pre="does not match the predicted circulating strains. Most recently, an" exact="influenza" post="vaccine made of purified recombinant HA antigens (https://www.cdc.gov/flu/protect/vaccine/qa_flublok-vaccine.htm) has"/>
  <result pre="to IIV. The remaining prophylactic option is the live attenuated" exact="influenza" post="vaccine (LAIV), which is associated with broader responses and"/>
  <result pre="responses. In addition, its administration mimics the usual route of" exact="influenza" post="virus infection that has been shown to provide more"/>
  <result pre="shown to provide more efficient cross-reactive cellular-mediated protection against heterologous" exact="influenza" post="viruses, important in cases where the vaccine and circulating"/>
  <result pre="in healthy children and non-pregnant adults. Independent of type, seasonal" exact="influenza" post="vaccines typically contain antigens from the two IAV subtypes"/>
  <result pre="circulating in humans [43,44]. Worryingly, over the past decade, seasonal" exact="influenza" post="vaccines have shown a low protection efficacy rate [34,38,45]."/>
  <result pre="[34,38,45]. In order to improve the effectiveness of current seasonal" exact="influenza" post="vaccines, a quadrivalent influenza vaccine formulation, including both IBV"/>
  <result pre="improve the effectiveness of current seasonal influenza vaccines, a quadrivalent" exact="influenza" post="vaccine formulation, including both IBV lineage components (Victoria- and"/>
  <result pre="2017–18 in the US [48,49]. However, for the current 2018–19" exact="influenza" post="season, LAIV will be included again among the eligible"/>
  <result pre="be included again among the eligible prophylactic options to prevent" exact="influenza" post="infections (https://www.aafp.org/news/health-of-the-public/20180226acipmtg-laiv.html). The variability in influenza vaccine efficiency is"/>
  <result pre="prophylactic options to prevent influenza infections (https://www.aafp.org/news/health-of-the-public/20180226acipmtg-laiv.html). The variability in" exact="influenza" post="vaccine efficiency is leading to an increasing concern on"/>
  <result pre="is leading to an increasing concern on how to combat" exact="influenza" post="virus infection and protect population from seasonal infections. Consequently,"/>
  <result pre="are necessary to prevent the morbidity and mortality associated with" exact="influenza" post="virus infections, as are studies aimed to better understand"/>
  <result pre="associated with the current LAIV. Public health concerns associated with" exact="influenza" post="viral infections in humans are intensified by the limited"/>
  <result pre="options to combat viral infections and prevent the rapid-spreading of" exact="influenza" post="viruses [50]. Up to now, only a few therapeutic"/>
  <result pre="Up to now, only a few therapeutic choices to control" exact="influenza" post="infections are licensed and they are limited to two"/>
  <result pre="2. IAV Genome Organization, Virion Structure, and Life Cycle Although" exact="influenza" post="viruses shar similar structural characteristics and comparable replication and"/>
  <result pre="complex at one end that pseudo-circularizes the vRNA [62,63,64]. Although" exact="influenza" post="vRNAs are single-stranded, the last nucleotides at their 5′"/>
  <result pre="could be implemented as potential LAIV for the treatment of" exact="influenza" post="viral infections. Likewise, information obtained from the viral polymerase"/>
  <result pre="targeting specific polymerase functions and/or components for the treatment of" exact="influenza" post="viral infections [78,83,84]. The replicase complex core of IAV"/>
  <result pre="in two phases (Figure 1C). In a first phase, the" exact="influenza" post="viral polymerase complex catalyzes the transcription of vRNA into"/>
  <result pre="viral polymerase will be decisive to understand the machinery of" exact="influenza" post="RNA synthesis. The three subunits of the polymerase complex"/>
  <result pre="their cellular localization and protein–protein interactions. 3.1. PB1 Subunit The" exact="influenza" post="PB1 component contains the RdRp catalytic site and is"/>
  <result pre="for the generation and identification of novel antivirals to treat" exact="influenza" post="infections [62,91]. 3.2. PB2 Subunit The main role of"/>
  <result pre="which is the site of the most significant sequelae of" exact="influenza" post="infection [28,36]. Current seasonal LAIV can be generated either"/>
  <result pre="or canine (A/canine/NY/dog23/09 H3N8) [118,127] and equine (A/equine/Ohio/03 H3N8) [140]" exact="influenza" post="viruses, a similar ts and att phenotype was observed"/>
  <result pre="and/or development. However, it is important emphasize that high resolution" exact="influenza" post="polymerase structure will have significant implications to understand the"/>
  <result pre="[151]. Similarly, Noton et al. described the characterization of an" exact="avian influenza" post="virus (A/chicken/Rostock/34 H7N1) ts NP mutant (M239L) (Table 1)"/>
  <result pre="Similarly, Noton et al. described the characterization of an avian" exact="influenza" post="virus (A/chicken/Rostock/34 H7N1) ts NP mutant (M239L) (Table 1)"/>
  <result pre="variants, distinct from the selected vaccine strain, during a given" exact="influenza" post="season can result in significant loss of vaccine effectiveness."/>
  <result pre="Centers of Excellence for Influenza Research and Surveillance CIV Canine" exact="influenza" post="virus(es) CKTC Chicken kidney tissue culture cRNA Complementary RNA"/>
  <result pre="cRNA Complementary RNA eIF4E Eukaryotic initiation factor 4E EIV Equine" exact="influenza" post="virus(es) FDA Food and Drug Administration HA Hemagglutinin HPAIV"/>
  <result pre="FDA Food and Drug Administration HA Hemagglutinin HPAIV Highly pathogenic" exact="avian influenza" post="virus(es) IAV Influenza A virus(es) IBV Influenza B virus(es)"/>
  <result pre="Food and Drug Administration HA Hemagglutinin HPAIV Highly pathogenic avian" exact="influenza" post="virus(es) IAV Influenza A virus(es) IBV Influenza B virus(es)"/>
  <result pre="C virus(es) IDV Influenza D virus(es) IFN Interferon IIV Inactivated" exact="influenza" post="vaccine(s) kDa Kilodalton LAIV Live attenuated influenza vaccine(s) LAV"/>
  <result pre="Interferon IIV Inactivated influenza vaccine(s) kDa Kilodalton LAIV Live attenuated" exact="influenza" post="vaccine(s) LAV Live attenuated vaccine(s) Len/17 A/Leningrad/134/17/57 H2N2 LAIV"/>
  <result pre="protein 2 PFU Plaque forming units pH1N1 Pandemic A/California/04/09 H1N1" exact="influenza" post="virus PR8 A/Puerto Rico/8/34 H1N1 influenza virus RBD Receptor"/>
  <result pre="pH1N1 Pandemic A/California/04/09 H1N1 influenza virus PR8 A/Puerto Rico/8/34 H1N1" exact="influenza" post="virus RBD Receptor binding domain RdRp Viral RNA-dependent RNA"/>
  <result pre="Soviet Socialist Republics WHO World Health Organization WSN A/WSN/33 H1N1" exact="influenza" post="virus WT Wild-type X31 Reassortant influenza virus containing the"/>
  <result pre="Organization WSN A/WSN/33 H1N1 influenza virus WT Wild-type X31 Reassortant" exact="influenza" post="virus containing the HA and NA genes of A/Hong"/>
  <result pre="NA genes of A/Hong Kong/1/68 H3N2 in the background of" exact="influenza" post="PR8 virus References References 1.ChiapponiC.FacciniS.De MattiaA.BaioniL.BarbieriI.RosignoliC.NigrelliA.FoniE.Detection of influenza D"/>
  <result pre="background of influenza PR8 virus References References 1.ChiapponiC.FacciniS.De MattiaA.BaioniL.BarbieriI.RosignoliC.NigrelliA.FoniE.Detection of" exact="influenza" post="D virus among swine and cattle, ItalyEmerg. Infect. Dis.20162235235410.3201/eid2202.15143926812282"/>
  <result pre="understanding of an emerging viral infection in swineSci. Rep.201771166010.1038/s41598-017-12012-328916759 3.SuS.FuX.LiG.KerlinF.VeitM.Novel" exact="influenza" post="D virus: Epidemiology, pathology, evolution and biological characteristicsVirulence201781580159110.1080/21505594.2017.136521628812422 4.BakerS.F.NogalesA.FinchC.TuffyK.M.DommW.PerezD.R.TophamD.J.Martinez-SobridoL.Influenza"/>
  <result pre="reservoirs and intermediate hosts: Dogs, horses, and new possibilities for" exact="influenza" post="virus exposure of humansJ. Virol.2015892990299410.1128/JVI.03146-1425540375 7.KanegaeY.SugitaS.EndoA.IshidaM.SenyaS.OsakoK.NeromeK.OyaA.Evolutionary pattern of the"/>
  <result pre="formationCell Host Microbe2010744045110.1016/j.chom.2010.05.00920542248 11.OsterhausA.D.RimmelzwaanG.F.MartinaB.E.BestebroerT.M.FouchierR.A.Influenza B virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 12.SmithD.B.GauntE.R.DigardP.TempletonK.SimmondsP.Detection of" exact="influenza" post="c virus but not influenza D virus in scottish"/>
  <result pre="virus in sealsScience20002881051105310.1126/science.288.5468.105110807575 12.SmithD.B.GauntE.R.DigardP.TempletonK.SimmondsP.Detection of influenza c virus but not" exact="influenza" post="D virus in scottish respiratory samplesJ. Clin. Virol.201674505310.1016/j.jcv.2015.11.03626655269 13.HengrungN.El"/>
  <result pre="OmariK.SeRNA MartinI.VreedeF.T.CusackS.RamboR.P.VonrheinC.BricogneG.StuartD.I.GrimesJ.M.et al.Crystal structure of the RNA-dependent RNA polymerase from" exact="influenza" post="c virusNature201552711411710.1038/nature1552526503046 14.SalemE.CookE.A.J.LbachaH.A.OlivaJ.AwoumeF.AploganG.L.HymannE.C.MuloiD.DeemS.L.AlaliS.et al.Serologic evidence for influenza c and"/>
  <result pre="RNA polymerase from influenza c virusNature201552711411710.1038/nature1552526503046 14.SalemE.CookE.A.J.LbachaH.A.OlivaJ.AwoumeF.AploganG.L.HymannE.C.MuloiD.DeemS.L.AlaliS.et al.Serologic evidence for" exact="influenza" post="c and d virus among ruminants and camelids, Africa,"/>
  <result pre="camelids, Africa, 1991–2015Emerg. Infect. Dis.2017231556155910.3201/eid2309.17034228820371 15.MolinariN.A.Ortega-SanchezI.R.MessonnierM.L.ThompsonW.W.WortleyP.M.WeintraubE.BridgesC.B.The annual impact of seasonal" exact="influenza" post="in the us: Measuring disease burden and costsVaccine2007255086509610.1016/j.vaccine.2007.03.04617544181 16.BarrI.G.McCauleyJ.CoxN.DanielsR.EngelhardtO.G.FukudaK.GrohmannG.HayA.KelsoA.KlimovA.et"/>
  <result pre="and genetic characteristics of seasonal Influenza A(H1N1), A(H3N2) and B" exact="influenza" post="viruses: Basis for the who recommendation on the composition"/>
  <result pre="viruses: Basis for the who recommendation on the composition of" exact="influenza" post="vaccines for use in the 2009–2010 northern hemisphere seasonVaccine2010281156116710.1016/j.vaccine.2009.11.04320004635"/>
  <result pre="the 2009–2010 northern hemisphere seasonVaccine2010281156116710.1016/j.vaccine.2009.11.04320004635 17.GrohskopfL.A.SokolowL.Z.BroderK.R.OlsenS.J.KarronR.A.JerniganD.B.BreseeJ.S.Prevention and control of seasonal" exact="influenza" post="with vaccinesMMWR Recomm. Rep.20166515410.15585/mmwr.rr6505a127560619 18.PaleseP.S.Orthomyxoviridae: The viruses and their"/>
  <result pre="and WilkinsLondon, UK200716471689 19.Byrd-LeotisL.CummingsR.D.SteinhauerD.A.The interplay between the host receptor and" exact="influenza" post="virus hemagglutinin and neuraminidaseInt. J. Mol. Sci.201718154110.3390/ijms180728714909 20.GaymardA.Le BriandN.FrobertE.LinaB.EscuretV.Functional"/>
  <result pre="Mol. Sci.201718154110.3390/ijms180728714909 20.GaymardA.Le BriandN.FrobertE.LinaB.EscuretV.Functional balance between neuraminidase and haemagglutinin in" exact="influenza" post="virusesClin. Microbiol. Infect.20162297598310.1016/j.cmi.2016.07.00727424943 21.ChenR.HolmesE.C.The evolutionary dynamics of human Influenza"/>
  <result pre="Evol.20086665566310.1007/s00239-008-9119-z18504518 22.GartenR.J.DavisC.T.RussellC.A.ShuB.LindstromS.BalishA.SessionsW.M.XuX.SkepnerE.DeydeV.et al.Antigenic and genetic characteristics of swine-origin 2009 A(H1N1)" exact="influenza" post="viruses circulating in humansScience200932519720110.1126/science.117622519465683 23.SmithG.J.VijaykrishnaD.BahlJ.LycettS.J.WorobeyM.PybusO.G.MaS.K.CheungC.L.RaghwaniJ.BhattS.et al.Origins and evolutionary genomics"/>
  <result pre="virus circulated between 1979 and 2003J. Virol.200478128171282810.1128/JVI.78.23.12817-12828.200415542634 26.HiteL.K.GlezenW.P.DemmlerG.J.MunozF.M.Medically attended pediatric" exact="influenza" post="during the resurgence of the victoria lineage of Influenza"/>
  <result pre="interference between Influenza A and B virusesArch. Virol.19827328729410.1007/BF013180827149996 30.MontoA.S.OhmitS.E.MarguliesJ.R.TalsmaA.Medical practice-based" exact="influenza" post="surveillance: Viral prevalence and assessment of morbidityAm. J. Epidemiol.199514150250610.1093/oxfordjournals.aje.a1174647900716"/>
  <result pre="treatment of Influenza A (H5N1) infectionN. Engl. J. Med.20053532667267210.1056/NEJMoa05451216371632 32.HurtA.C.HolienJ.K.ParkerM.KelsoA.BarrI.G.Zanamivir-resistant" exact="influenza" post="viruses with a novel neuraminidase mutationJ. Virol.200983103661037310.1128/JVI.01200-0919641000 33.MontoA.S.McKimm-BreschkinJ.L.MackenC.HampsonA.W.HayA.KlimovA.TashiroM.WebsterR.G.AymardM.HaydenF.G.et al.Detection"/>
  <result pre="viruses with a novel neuraminidase mutationJ. Virol.200983103661037310.1128/JVI.01200-0919641000 33.MontoA.S.McKimm-BreschkinJ.L.MackenC.HampsonA.W.HayA.KlimovA.TashiroM.WebsterR.G.AymardM.HaydenF.G.et al.Detection of" exact="influenza" post="viruses resistant to neuraminidase inhibitors in global surveillance during"/>
  <result pre="years of their useAntimicrob. Agents Chemother.2006502395240210.1128/AAC.01339-0516801417 34.OsterholmM.T.KelleyN.S.SommerA.BelongiaE.A.Efficacy and effectiveness of" exact="influenza" post="vaccines: A systematic review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 35.FinchC.LiW.PerezD.R.Design"/>
  <result pre="review and meta-analysisLancet Infect. Dis.201212364410.1016/S1473-3099(11)70295-X22032844 35.FinchC.LiW.PerezD.R.Design of alteRNAtive live attenuated" exact="influenza" post="virus vaccinesCurr. Top. Microbiol. Immunol.201538620523525005928 36.GirardM.P.CherianT.PervikovY.KienyM.P.A review of vaccine"/>
  <result pre="research and development: Human acute respiratory infectionsVaccine2005235708572410.1016/j.vaccine.2005.07.04616154667 37.KrammerF.PaleseP.SteelJ.Advances in universal" exact="influenza" post="virus vaccine design and antibody mediated therapies based on"/>
  <result pre="Top. Microbiol. Immunol.201538630132125007847 38.NogalesA.Martinez-SobridoL.Reverse genetics approaches for the development of" exact="influenza" post="vaccinesInt. J. Mol. Sci.2016182010.3390/ijms1801002028025504 39.DiazGranadosC.A.DunningA.J.KimmelM.KirbyD.TreanorJ.CollinsA.PollakR.ChristoffJ.EarlJ.LandolfiV.et al.Efficacy of high-dose versus"/>
  <result pre="vaccinesInt. J. Mol. Sci.2016182010.3390/ijms1801002028025504 39.DiazGranadosC.A.DunningA.J.KimmelM.KirbyD.TreanorJ.CollinsA.PollakR.ChristoffJ.EarlJ.LandolfiV.et al.Efficacy of high-dose versus standard-dose" exact="influenza" post="vaccine in older adultsN. Engl. J. Med.201437163564510.1056/NEJMoa131572725119609 40.TsangP.GorseG.J.StroutC.B.SperlingM.GreenbergD.P.Ozol-GodfreyA.DiazGranadosC.LandolfiV.Immunogenicity and"/>
  <result pre="Med.201437163564510.1056/NEJMoa131572725119609 40.TsangP.GorseG.J.StroutC.B.SperlingM.GreenbergD.P.Ozol-GodfreyA.DiazGranadosC.LandolfiV.Immunogenicity and safety of fluzone ® intradermal and high-dose" exact="influenza" post="vaccines in older adults &amp;gt;/=65 years of age: A"/>
  <result pre="age: A randomized, controlled, phase II trialVaccine2014322507251710.1016/j.vaccine.2013.09.07424120672 41.PicaN.PaleseP.Toward a universal" exact="influenza" post="virus vaccine: Prospects and challengesAnnu. Rev. Med.20136418920210.1146/annurev-med-120611-14511523327522 42.GorseG.J.BelsheR.B.MunnN.J.Superiority of"/>
  <result pre="vaccines in older, chronically ill adultsChest199110097798410.1378/chest.100.4.9771914615 43.PronkerE.S.ClaassenE.OsterhausA.D.Development of new generation" exact="influenza" post="vaccines: Recipes for success?Vaccine2012307344734710.1016/j.vaccine.2012.09.07123044407 44.SunW.Approval Letter-Fluarix Quadrivalent (bl 125127/513)U.S."/>
  <result pre="(FDA)Washington, DC, USA2012 45.PyoH.M.ZhouY.Protective efficacy of intranasally administered bivalent live" exact="influenza" post="vaccine and immunological mechanisms underlying the protectionVaccine2014323835384210.1016/j.vaccine.2014.04.06524837774 46.CaspardH.MalloryR.M.YuJ.AmbroseC.S.Live-attenuated influenza"/>
  <result pre="live influenza vaccine and immunological mechanisms underlying the protectionVaccine2014323835384210.1016/j.vaccine.2014.04.06524837774 46.CaspardH.MalloryR.M.YuJ.AmbroseC.S.Live-attenuated" exact="influenza" post="vaccine effectiveness in children from 2009 to 2015–2016: A"/>
  <result pre="comparison of immunogenicity and safety of quadrivalent recombinant versus inactivated" exact="influenza" post="vaccine in healthy adults 18–49 years of ageJ. Infect."/>
  <result pre="years of ageJ. Infect. Dis.20172161219122610.1093/infdis/jix47828968871 48.GrohskopfL.A.SokolowL.Z.BroderK.R.WalterE.B.BreseeJ.S.FryA.M.JerniganD.B.Prevention and control of seasonal" exact="influenza" post="with vaccines: Recommendations of the advisory committee on immunization"/>
  <result pre="Recommendations of the advisory committee on immunization practices-united states, 2017–18" exact="influenza" post="seasonAm. J. Transplant.2017172970298210.1111/ajt.1451129083555 49.MurrayJ.S.Prevention and control of influenza in"/>
  <result pre="states, 2017–18 influenza seasonAm. J. Transplant.2017172970298210.1111/ajt.1451129083555 49.MurrayJ.S.Prevention and control of" exact="influenza" post="in children during the 2016–2017 seasonal epidemicJ. Spec. Pediatr."/>
  <result pre="africaEmerg. Infect. Dis.2008141809181010.3201/eid1411.08095818976580 57.BloomJ.D.GongL.I.BaltimoreD.Permissive secondary mutations enable the evolution of" exact="influenza" post="oseltamivir resistanceScience20103281272127510.1126/science.118781620522774 58.BakerS.F.NogalesA.Martinez-SobridoL.Downregulating viral gene expression: Codon usage bias"/>
  <result pre="61.EisfeldA.J.NeumannG.KawaokaY.At the centre: Influenza A virus ribonucleoproteinsNat. Rev. Microbiol.201513284110.1038/nrmicro336725417656 62.Resa-InfanteP.JorbaN.ColomaR.OrtinJ.The" exact="influenza" post="virus RNA synthesis machine: Advances in its structure and"/>
  <result pre="bound to the viral RNA promoterNature201451635536010.1038/nature1400825409142 64.ArranzR.ColomaR.ChichonF.J.ConesaJ.J.CarrascosaJ.L.ValpuestaJ.M.OrtinJ.Martin-BenitoJ.The structure of native" exact="influenza" post="virion ribonucleoproteinsScience20123381634163710.1126/science.122817223180776 65.RobertsonJ.S.5′ and 3′ terminal nucleotide sequences of"/>
  <result pre="3′ terminal nucleotide sequences of the RNA genome segments of" exact="influenza" post="virusNucleic Acids Res.197963745375710.1093/nar/6.12.3745493121 66.HuangT.S.PaleseP.KrystalM.Determination of influenza virus proteins required"/>
  <result pre="RNA genome segments of influenza virusNucleic Acids Res.197963745375710.1093/nar/6.12.3745493121 66.HuangT.S.PaleseP.KrystalM.Determination of" exact="influenza" post="virus proteins required for genome replicationJ. Virol.199064566956732214032 67.HeldtF.S.FrensingT.ReichlU.Modeling the"/>
  <result pre="required for genome replicationJ. Virol.199064566956732214032 67.HeldtF.S.FrensingT.ReichlU.Modeling the intracellular dynamics of" exact="influenza" post="virus replication to understand the control of viral RNA"/>
  <result pre="viral RNA synthesisJ. Virol.2012867806781710.1128/JVI.00080-1222593159 68.LambR.A.ChoppinP.W.The gene structure and replication of" exact="influenza" post="virusAnnu. Rev. Biochem.19835246750610.1146/annurev.bi.52.070183.0023436351727 69.PlotchS.J.BouloyM.UlmanenI.KrugR.M.A unique cap(m7gpppxm)-dependent influenza virion endonuclease"/>
  <result pre="and replication of influenza virusAnnu. Rev. Biochem.19835246750610.1146/annurev.bi.52.070183.0023436351727 69.PlotchS.J.BouloyM.UlmanenI.KrugR.M.A unique cap(m7gpppxm)-dependent" exact="influenza" post="virion endonuclease cleaves capped RNAs to generate the primers"/>
  <result pre="primers that initiate viral RNA transcriptionCell19812384785810.1016/0092-8674(81)90449-96261960 70.NayakD.P.HuiE.K.BarmanS.Assembly and budding of" exact="influenza" post="virusVirus Res.200410614716510.1016/j.virusres.2004.08.01215567494 71.RossmanJ.S.LambR.A.Influenza virus assembly and buddingVirology201141122923610.1016/j.virol.2010.12.00321237476 72.SchmittA.P.LambR.A.Influenza virus"/>
  <result pre="contributes to pathogenicity in a mouse modelJ. Virol.200983123251233510.1128/JVI.01373-0919793828 76.SteelJ.LowenA.C.MubarekaS.PaleseP.Transmission of" exact="influenza" post="virus in a mammalian host is increased by PB2"/>
  <result pre="in PA, NP, and HA of a pandemic (H1N1) 2009" exact="influenza" post="virus contribute to its adaptation to miceVirus Res.201115812412910.1016/j.virusres.2011.03.02221458512 78.PflugA.LukarskaM.Resa-InfanteP.ReichS.CusackS.Structural"/>
  <result pre="to miceVirus Res.201115812412910.1016/j.virusres.2011.03.02221458512 78.PflugA.LukarskaM.Resa-InfanteP.ReichS.CusackS.Structural insights into RNA synthesis by the" exact="influenza" post="virus transcription-replication machineVirus Res.201723410311710.1016/j.virusres.2017.01.01328115197 79.Crescenzo-ChaigneB.NaffakhN.van der WerfS.Comparative analysis of"/>
  <result pre="WerfS.Comparative analysis of the ability of the polymerase complexes of" exact="influenza" post="viruses type A, B and C to assemble into"/>
  <result pre="in vivoVirology199926534235310.1006/viro.1999.005910600605 80.EngelhardtO.G.FodorE.Functional association between viral and cellular transcription during" exact="influenza" post="virus infectionRev. Med. Virol.20061632934510.1002/rmv.51216933365 81.ReichS.GuilligayD.PflugA.MaletH.BergerI.CrepinT.HartD.LunardiT.NanaoM.RuigrokR.W.et al.Structural insight into cap-snatching"/>
  <result pre="Virol.20061632934510.1002/rmv.51216933365 81.ReichS.GuilligayD.PflugA.MaletH.BergerI.CrepinT.HartD.LunardiT.NanaoM.RuigrokR.W.et al.Structural insight into cap-snatching and RNA synthesis by" exact="influenza" post="polymeraseNature201451636136610.1038/nature1400925409151 82.ThierryE.GuilligayD.KosinskiJ.BockT.GaudonS.RoundA.PflugA.HengrungN.El OmariK.BaudinF.et al.Influenza polymerase can adopt an alternative"/>
  <result pre="synthesisNat. Rev. Microbiol.20161447949310.1038/nrmicro.2016.8727396566 84.LukarskaM.FournierG.PflugA.Resa-InfanteP.ReichS.NaffakhN.CusackS.Structural basis of an essential interaction between" exact="influenza" post="polymerase and pol II CTDNature201754111712110.1038/nature2059428002402 85.de FariasS.T.Dos Santos JuniorA.P.RegoT.G.JoseM.V.Origin"/>
  <result pre="Santos JuniorA.P.RegoT.G.JoseM.V.Origin and evolution of RNA-dependent RNA polymeraseFront. Genet.2017812510.3389/fgene.2017.0012528979293 86.NogalesA.Marquez-JuradoS.GalanC.EnjuanesL.AlmazanF.Transmissible" exact="gastroenteritis" post="coronavirus RNA-dependent RNA polymerase and nonstructural proteins 2, 3,"/>
  <result pre="particlesJ. Virol.2012861261126610.1128/JVI.06428-1122090122 87.GuilligayD.TarendeauF.Resa-InfanteP.ColomaR.CrepinT.SehrP.LewisJ.RuigrokR.W.OrtinJ.HartD.J.et al.The structural basis for cap binding by" exact="influenza" post="virus polymerase subunit PB2Nat. Struct. Mol. Biol.20081550050610.1038/nsmb.142118454157 88.DengT.VreedeF.T.BrownleeG.G.Different de"/>
  <result pre="Mol. Biol.20081550050610.1038/nsmb.142118454157 88.DengT.VreedeF.T.BrownleeG.G.Different de novo initiation strategies are used by" exact="influenza" post="virus RNA polymerase on its cRNA and viral RNA"/>
  <result pre="during viral RNA replicationJ. Virol.2006802337234810.1128/JVI.80.5.2337-2348.200616474140 89.YuanP.BartlamM.LouZ.ChenS.ZhouJ.HeX.LvZ.GeR.LiX.DengT.et al.Crystal structure of an" exact="avian influenza" post="polymerase PAN reveals an endonuclease active siteNature200945890991310.1038/nature0772019194458 90.StubbsT.M.Te VelthuisA.J.The"/>
  <result pre="viral RNA replicationJ. Virol.2006802337234810.1128/JVI.80.5.2337-2348.200616474140 89.YuanP.BartlamM.LouZ.ChenS.ZhouJ.HeX.LvZ.GeR.LiX.DengT.et al.Crystal structure of an avian" exact="influenza" post="polymerase PAN reveals an endonuclease active siteNature200945890991310.1038/nature0772019194458 90.StubbsT.M.Te VelthuisA.J.The"/>
  <result pre="Influenza A virusFuture Virol.2014986387610.2217/fvl.14.6625431616 91.SuC.Y.ChengT.J.LinM.I.WangS.Y.HuangW.I.Lin-ChuS.Y.ChenY.H.WuC.Y.LaiM.M.ChengW.C.et al.High-throughput identification of compounds targeting" exact="influenza" post="RNA-dependent RNA polymerase activityProc. Natl. Acad. Sci. USA2010107191511915610.1073/pnas.101359210720974907 92.CarrS.M.CarneroE.Garcia-SastreA.BrownleeG.G.FodorE.Characterization"/>
  <result pre="92.CarrS.M.CarneroE.Garcia-SastreA.BrownleeG.G.FodorE.Characterization of a mitochondrial-targeting signal in the PB2 protein of" exact="influenza" post="virusesVirology200634449250810.1016/j.virol.2005.08.04116242167 93.WoodfinB.M.KazimA.L.Interaction of the amino-terminus of an influenza virus"/>
  <result pre="protein of influenza virusesVirology200634449250810.1016/j.virol.2005.08.04116242167 93.WoodfinB.M.KazimA.L.Interaction of the amino-terminus of an" exact="influenza" post="virus protein with mitochondriaArch. Biochem. Biophys.199330642743010.1006/abbi.1993.15338215446 94.NilssonB.E.Te VelthuisA.J.FodorE.Role of"/>
  <result pre="lies on the surface of a discrete, folded domain of" exact="influenza" post="virus polymerase PB2 subunitPLoS Pathog.20084e100013610.1371/journal.ppat.100013618769709 96.PooleE.EltonD.MedcalfL.DigardP.Functional domains of the"/>
  <result pre="Influenza A virus polymerase host restrictionNature201652910110410.1038/nature1647426738596 100.DiasA.BouvierD.CrepinT.McCarthyA.A.HartD.J.BaudinF.CusackS.RuigrokR.W.The cap-snatching endonuclease of" exact="influenza" post="virus polymerase resides in the PA subunitNature200945891491810.1038/nature0774519194459 101.KowalinskiE.ZubietaC.WolkerstorferA.SzolarO.H.RuigrokR.W.CusackS.Structural analysis"/>
  <result pre="specific metal chelating inhibitor binding to the endonuclease domain of" exact="influenza" post="pH1N1 (2009) polymerasePLoS Pathog.20128e100283110.1371/journal.ppat.100283122876177 102.CrepinT.DiasA.PalenciaA.SwaleC.CusackS.RuigrokR.W.Mutational and metal binding analysis"/>
  <result pre="and metal binding analysis of the endonuclease domain of the" exact="influenza" post="virus polymerase PA subunitJ. Virol.2010849096910410.1128/JVI.00995-1020592097 103.NogalesA.RodriguezL.DeDiegoM.L.TophamD.J.Martinez-SobridoL.Interplay of PA-X and"/>
  <result pre="for expression of a model RNA templateVirology199723520921710.1006/viro.1997.86829281500 108.HondaA.UedaK.NagataK.IshihamaA.RNA polymerase of" exact="influenza" post="virus: Role of np in RNA chain elongationJ. Biochem.19881041021102610.1093/oxfordjournals.jbchem.a1225693243763"/>
  <result pre="components required for the initiation of unprimed RNA synthesis by" exact="influenza" post="virus RNA polymeraseNucleic Acids Res.20023042943810.1093/nar/30.2.42911788704 110.NewcombL.L.KuoR.L.YeQ.JiangY.TaoY.J.KrugR.M.Interaction of the Influenza"/>
  <result pre="viral RNA replicationJ. Virol.200983293610.1128/JVI.02293-0718945782 111.ZhangS.WengL.GengL.WangJ.ZhouJ.DeubelV.BuchyP.ToyodaT.Biochemical and kinetic analysis of the" exact="influenza" post="virus RNA polymerase purified from insect cellsBiochem. Biophys. Res."/>
  <result pre="A virus ribonucleoprotein complexesNat. Commun.20134159110.1038/ncomms258923481399 113.BiswasS.K.BoutzP.L.NayakD.P.Influenza virus nucleoprotein interacts with" exact="influenza" post="virus polymerase proteinsJ. Virol.199872549355019621005 114.OzawaM.FujiiK.MuramotoY.YamadaS.YamayoshiS.TakadaA.GotoH.HorimotoT.KawaokaY.Contributions of two nuclear localization"/>
  <result pre="A virus nucleoprotein to viral replicationJ. Virol.200781304110.1128/JVI.01434-0617050598 115.BouloS.AkarsuH.RuigrokR.W.BaudinF.Nuclear traffic of" exact="influenza" post="virus proteins and ribonucleoprotein complexesVirus Res.2007124122110.1016/j.virusres.2006.09.01317081640 116.O’NeillR.E.TalonJ.PaleseP.The influenza virus"/>
  <result pre="traffic of influenza virus proteins and ribonucleoprotein complexesVirus Res.2007124122110.1016/j.virusres.2006.09.01317081640 116.O’NeillR.E.TalonJ.PaleseP.The" exact="influenza" post="virus nep (ns2 protein) mediates the nuclear export of"/>
  <result pre="nuclear export of viral ribonucleoproteinsEMBO J.19981728829610.1093/emboj/17.1.2889427762 117.NishiyamaS.IkegamiT.Temperature-sensitive mutations for live-attenuated" exact="rift valley fever" post="vaccines: Implications from other RNA virusesFront. Microbiol.2015678710.3389/fmicb.2015.0078726322023 118.NogalesA.RodriguezL.ChaucheC.HuangK.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez-SobridoL.Temperature-sensitive live-attenuated"/>
  <result pre="vaccines: Implications from other RNA virusesFront. Microbiol.2015678710.3389/fmicb.2015.0078726322023 118.NogalesA.RodriguezL.ChaucheC.HuangK.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez-SobridoL.Temperature-sensitive live-attenuated canine" exact="influenza" post="virus H3N8 vaccineJ. Virol.20179110.1128/JVI.02211-1627928017 119.TobitaK.TanakaT.GotoH.FengS.Y.Temperature-sensitive Influenza A virus clones"/>
  <result pre="Virol.198375172710.1007/BF013141246830443 120.CoxN.J.KitameF.KendalA.P.MaassabH.F.NaeveC.Identification of sequence changes in the cold-adapted, live attenuated" exact="influenza" post="vaccine strain, A/Ann Arbor/6/60 (H2N2)Virology198816755456710.1016/0042-6822(88)90118-32974219 121.BelsheR.B.EdwardsK.M.VesikariT.BlackS.V.WalkerR.E.HultquistM.KembleG.ConnorE.M.GroupC.-T.C.E.S.Live attenuated versus inactivated"/>
  <result pre="influenza vaccine strain, A/Ann Arbor/6/60 (H2N2)Virology198816755456710.1016/0042-6822(88)90118-32974219 121.BelsheR.B.EdwardsK.M.VesikariT.BlackS.V.WalkerR.E.HultquistM.KembleG.ConnorE.M.GroupC.-T.C.E.S.Live attenuated versus inactivated" exact="influenza" post="vaccine in infants and young childrenN. Engl. J. Med.200735668569610.1056/NEJMoa06536817301299"/>
  <result pre="infants and young childrenN. Engl. J. Med.200735668569610.1056/NEJMoa06536817301299 122.MaassabH.F.Plaque formation of" exact="influenza" post="virus at 25 °CNature196821964564610.1038/219645a05665725 123.SnyderM.H.BettsR.F.DeBordeD.TierneyE.L.ClementsM.L.HerringtonD.SearsS.D.DolinR.MaassabH.F.MurphyB.R.Four viral genes independently contribute"/>
  <result pre="reassortant virus vaccinesJ. Virol.1988624884953336068 124.MaassabH.F.BryantM.L.The development of live attenuated cold-adapted" exact="influenza" post="virus vaccine for humansRev. Med. Virol.1999923724410.1002/(SICI)1099-1654(199910/12)9:4&amp;lt;237::AID-RMV252&amp;gt;3.0.CO;2-G10578119 125.WongS.S.WebbyR.J.Traditional and new"/>
  <result pre="influenza virus vaccine for humansRev. Med. Virol.1999923724410.1002/(SICI)1099-1654(199910/12)9:4&amp;lt;237::AID-RMV252&amp;gt;3.0.CO;2-G10578119 125.WongS.S.WebbyR.J.Traditional and new" exact="influenza" post="vaccinesClin. Microbiol. Rev.20132647649210.1128/CMR.00097-1223824369 126.CoxA.BakerS.F.NogalesA.Martinez-SobridoL.DewhurstS.Development of a mouse-adapted live attenuated"/>
  <result pre="influenza vaccinesClin. Microbiol. Rev.20132647649210.1128/CMR.00097-1223824369 126.CoxA.BakerS.F.NogalesA.Martinez-SobridoL.DewhurstS.Development of a mouse-adapted live attenuated" exact="influenza" post="virus that permits in vivo analysis of enhancements to"/>
  <result pre="vivo analysis of enhancements to the safety of live attenuated" exact="influenza" post="virus vaccineJ. Virol.2015893421342610.1128/JVI.02636-1425552727 127.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated influenza vaccine for"/>
  <result pre="of live attenuated influenza virus vaccineJ. Virol.2015893421342610.1128/JVI.02636-1425552727 127.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated" exact="influenza" post="vaccine for H3N2 canine influenza virusVirology20175049610610.1016/j.virol.2017.01.02028167384 128.GhendonY.Z.Molecular characteristics and"/>
  <result pre="vaccineJ. Virol.2015893421342610.1128/JVI.02636-1425552727 127.RodriguezL.NogalesA.ReillyE.C.TophamD.J.MurciaP.R.ParrishC.R.Martinez SobridoL.A live-attenuated influenza vaccine for H3N2 canine" exact="influenza" post="virusVirology20175049610610.1016/j.virol.2017.01.02028167384 128.GhendonY.Z.Molecular characteristics and biological properties (genetic markers) of"/>
  <result pre="properties (genetic markers) of candidate strains for preparation of live" exact="influenza" post="virus vaccinesBull. World Health Organ.1984624934996331910 129.GhendonY.Z.PolezhaevF.I.LisovskayaK.V.MedvedevaT.E.AlexandrovaG.I.KlimovA.I.Recombinant cold-adapted attenuated Influenza"/>
  <result pre="phenotype of a master donor virus used in live attenuated" exact="influenza" post="vaccines: A/Leningrad/134/17/57 (H2N2)Virology201141229730510.1016/j.virol.2011.01.00421315402 132.Isakova-SivakI.RudenkoL.Safety, immunogenicity and infectivity of new"/>
  <result pre="A/Leningrad/134/17/57 (H2N2)Virology201141229730510.1016/j.virol.2011.01.00421315402 132.Isakova-SivakI.RudenkoL.Safety, immunogenicity and infectivity of new live attenuated" exact="influenza" post="vaccinesExpert Rev. Vaccines2015141313132910.1586/14760584.2015.107588326289975 133.TsfasmanT.M.MarkushinS.G.AkopovaI.I.GhendonY.Z.Molecular mechanisms of reversion to the"/>
  <result pre="Influenza A/Leningrad/134/57 (H2N2) virusVirology199218679579710.1016/0042-6822(92)90050-Y1733114 135.KlimovA.I.EgorovA.Y.GushchinaM.I.MedvedevaT.E.GambleW.C.RudenkoL.G.AlexandrovaG.I.CoxN.J.Genetic stability of cold-adapted A/Leningrad/134/47/57 (H2N2)" exact="influenza" post="virus: Sequence analysis of live cold-adapted reassortant vaccine strains"/>
  <result pre="and after replication in childrenJ. Gen. Virol.1995761521152510.1099/0022-1317-76-6-15217782782 136.KendalA.P.Cold-adapted live attenuated" exact="influenza" post="vaccines developed in Russia: Can they contribute to meeting"/>
  <result pre="in Russia: Can they contribute to meeting the needs for" exact="influenza" post="control in other countries?Eur. J. Epidemiol.19971359160910.1023/A:10073275058629258574 137.ChanW.ZhouH.KembleG.JinH.The cold adapted"/>
  <result pre="A/Ann Arbor/6/60 virus, the master donor virus for live attenuated" exact="influenza" post="vaccines, has multiple defects in replication at the restrictive"/>
  <result pre="in replication at the restrictive temperatureVirology200838030431110.1016/j.virol.2008.07.02718768193 138.HeW.WangW.HanH.WangL.ZhangG.GaoB.Molecular basis of live-attenuated" exact="influenza" post="virusPLoS ONE20138e6041310.1371/journal.pone.006041323555969 139.ZhouB.LiY.SpeerS.D.SubbaA.LinX.WentworthD.E.Engineering temperature sensitive live attenuated influenza vaccines"/>
  <result pre="of live-attenuated influenza virusPLoS ONE20138e6041310.1371/journal.pone.006041323555969 139.ZhouB.LiY.SpeerS.D.SubbaA.LinX.WentworthD.E.Engineering temperature sensitive live attenuated" exact="influenza" post="vaccines from emerging virusesVaccine2012303691370210.1016/j.vaccine.2012.03.02522449422 140.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a novel equine"/>
  <result pre="influenza vaccines from emerging virusesVaccine2012303691370210.1016/j.vaccine.2012.03.02522449422 140.RodriguezL.ReedyS.NogalesA.MurciaP.R.ChambersT.M.Martinez-SobridoL.Development of a novel equine" exact="influenza" post="virus live-attenuated vaccineVirology2018516768510.1016/j.virol.2018.01.00529331866 141.JinH.ZhouH.LuB.KembleG.Imparting temperature sensitivity and attenuation in"/>
  <result pre="141.JinH.ZhouH.LuB.KembleG.Imparting temperature sensitivity and attenuation in ferrets to a/puerto rico/8/34" exact="influenza" post="virus by transferring the genetic signature for temperature sensitivity"/>
  <result pre="Arbor/6/60J. Virol.20047899599810.1128/JVI.78.2.995-998.200414694130 142.YoungnerJ.S.Whitaker-DowlingP.ChambersT.M.RushlowK.E.SebringR.Derivation and characterization of a live attenuated equine" exact="influenza" post="vaccine virusAm. J. Vet. Res.2001621290129410.2460/ajvr.2001.62.129011497453 143.ChambersT.M.HollandR.E.TudorL.R.TownsendH.G.CookA.BogdanJ.LunnD.P.HusseyS.Whitaker-DowlingP.YoungnerJ.S.et al.A new modified"/>
  <result pre="virusAm. J. Vet. Res.2001621290129410.2460/ajvr.2001.62.129011497453 143.ChambersT.M.HollandR.E.TudorL.R.TownsendH.G.CookA.BogdanJ.LunnD.P.HusseyS.Whitaker-DowlingP.YoungnerJ.S.et al.A new modified live equine" exact="influenza" post="virus vaccine: Phenotypic stability, restricted spread and efficacy against"/>
  <result pre="Respi. viruses2010433934410.1111/j.1750-2659.2010.00176.x20958927 145.PaillotR.A systematic review of recent advances in equine" exact="influenza" post="vaccinationVaccines2014279783110.3390/vaccines204079726344892 146.ParkA.W.DalyJ.M.LewisN.S.SmithD.J.WoodJ.L.GrenfellB.T.Quantifying the impact of immune escape on transmission"/>
  <result pre="immune escape on transmission dynamics of influenzaScience200932672672810.1126/science.117598019900931 147.LeeK.H.SeoS.U.SongJ.M.LeeC.M.KimH.A.SeongB.L.Characterization of live" exact="influenza" post="vaccine donor strain derived from cold-adaptation of X-31 virusVaccine2006241966197410.1016/j.vaccine.2005.10.05116343703"/>
  <result pre="X-31 virusVaccine2006241966197410.1016/j.vaccine.2005.10.05116343703 148.JangY.H.JungE.J.LeeK.H.ByunY.H.YangS.W.SeongB.L.Genetic analysis of attenuation markers of cold-adapted X-31" exact="influenza" post="live vaccine donor strainVaccine2016341343134910.1016/j.vaccine.2016.01.05326851733 149.ZhangW.TuJ.ZhaoZ.ChenH.JinM.The new temperature-sensitive mutation pa-f35s"/>
  <result pre="temperature-sensitive mutation pa-f35s for developing recombinant avian live attenuated H5N1" exact="influenza" post="vaccineVirol. J.201299710.1186/1743-422X-9-9722621130 150.Da CostaB.SaussetA.MunierS.GhounarisA.NaffakhN.Le GofficR.DelmasB.Temperature-sensitive mutants in the Influenza"/>
  <result pre="and result in viral attenuationJ. Virol.2015896376639010.1128/JVI.00589-1525855727 151.TsybalovaL.M.GorevN.E.PotapchukM.V.RepkoI.A.KorotkovA.V.SergeevaM.V.KomissarovA.B.PisarevaM.M.KuznetsovV.V.GrudininM.P.et al.characterization of cold-adapted" exact="influenza" post="strain A/Hongkong/1/68/162/35 as a potential donor of attenuation and"/>
  <result pre="A/Wsn/33 virus by altering the basic amino acid domain of" exact="influenza" post="virus matrix proteinJ. Virol.2004789585959110.1128/JVI.78.18.9585-9591.200415331690 154.GaraigortaU.FalconA.M.OrtinJ.Genetic analysis of influenza virus"/>
  <result pre="domain of influenza virus matrix proteinJ. Virol.2004789585959110.1128/JVI.78.18.9585-9591.200415331690 154.GaraigortaU.FalconA.M.OrtinJ.Genetic analysis of" exact="influenza" post="virus ns1 gene: A temperature-sensitive mutant shows defective formation"/>
  <result pre="human Influenza A virusesJ. Virol.20179110.1128/JVI.01930-1628003482 156.ZhouB.MeliopoulosV.A.WangW.LinX.StuckerK.M.HalpinR.A.StockwellT.B.Schultz-CherryS.WentworthD.E.Reversion of cold-adapted live attenuated" exact="influenza" post="vaccine into a pathogenic virusJ. Virol.2016908454846310.1128/JVI.00163-1627440882 157.ChenZ.AspelundA.KembleG.JinH.Genetic mapping of"/>
  <result pre="of B/Ann Arbor/1/66, the master donor virus for live attenuated" exact="influenza" post="vaccines (flumist)Virology200634541642310.1016/j.virol.2005.10.00516289204 158.DonabedianA.M.DeBordeD.C.CookS.SmitkaC.W.MaassabH.F.A mutation in the pa protein gene"/>
  <result pre="mutation in the pa protein gene of cold-adapted B/Ann Arbor/1/66" exact="influenza" post="virus associated with reversion of temperature sensitivity and attenuated"/>
  <result pre="temperature sensitivity and attenuated virulenceVirology198816344445110.1016/0042-6822(88)90285-13354203 159.DonabedianA.M.DeBordeD.C.MaassabH.F.Genetics of cold-adapted B/Ann Arbor/1/66" exact="influenza" post="virus reassortants: The acidic polymerase (PA) protein gene confers"/>
  <result pre="control the expression of the temperature-sensitive phenotype of cold-adapted B/Ussr/60/69" exact="influenza" post="master donor virusJ. Gen. Virol.20109193193710.1099/vir.0.017996-020007357 162.PerezD.R.Garcia-SastreA.H5N1, a wealth of"/>
  <result pre="of importin-alpha isoforms governs cell tropism and host adaptation of" exact="influenza" post="virusNat. Commun.2011215610.1038/ncomms115821245837 164.JinH.LuB.ZhouH.MaC.ZhaoJ.YangC.F.KembleG.GreenbergH.Multiple amino acid residues confer temperature sensitivity"/>
  <result pre="Commun.2011215610.1038/ncomms115821245837 164.JinH.LuB.ZhouH.MaC.ZhaoJ.YangC.F.KembleG.GreenbergH.Multiple amino acid residues confer temperature sensitivity to human" exact="influenza" post="virus vaccine strains (flumist) derived from cold-adapted A/Ann Arbor/6/60Virology2003306182410.1016/S0042-6822(02)00035-112620793"/>
  <result pre="intracellular localization of M1J. Virol.2012861522153010.1128/JVI.06230-1122090133 167.AliA.AvalosR.T.PonimaskinE.NayakD.P.Influenza virus assembly: Effect of" exact="influenza" post="virus glycoproteins on the membrane association of M1 proteinJ."/>
  <result pre="glycoproteins on the membrane association of M1 proteinJ. Virol.2000748709871910.1128/JVI.74.18.8709-8719.200010954572 168.ChenB.J.LeserG.P.JacksonD.LambR.A.The" exact="influenza" post="virus M2 protein cytoplasmic tail interacts with the M1"/>
  <result pre="assembly at the site of virus buddingJ. Virol.200882100591007010.1128/JVI.01184-0818701586 169.NogalesA.DeDiegoM.L.TophamD.J.Martinez-SobridoL.Rearrangement of" exact="influenza" post="virus spliced segments for the development of live-attenuated vaccinesJ."/>
  <result pre="for the development of live-attenuated vaccinesJ. Virol.2016906291630210.1128/JVI.00410-1627122587 170.IwasakiA.PillaiP.S.Innate immunity to" exact="influenza" post="virus infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 171.HaleB.G.RandallR.E.OrtinJ.JacksonD.The multifunctional NS1 protein of"/>
  <result pre="Virol.2008892359237610.1099/vir.0.2008/004606-018796704 172.FalconA.M.MarionR.M.ZurcherT.GomezP.PortelaA.NietoA.OrtinJ.Defective RNA replication and late gene expression in temperature-sensitive" exact="influenza" post="viruses expressing deleted forms of the NS1 proteinJ. Virol.2004783880388810.1128/JVI.78.8.3880-3888.200415047804"/>
  <result pre="the NS1 protein grow efficiently in vero cellsJ. Virol.199872643764419658085 174.NogalesA.HuangK.ChaucheC.DeDiegoM.L.MurciaP.R.ParrishC.R.Martinez-SobridoL.Canine" exact="influenza" post="viruses with modified NS1 proteins for the development of"/>
  <result pre="H3N2 human Influenza A virusesJ. Virol.2016909693971110.1128/JVI.01039-1627535054 176.BelsheR.B.NewmanF.K.WilkinsK.GrahamI.L.BabusisE.EwellM.FreyS.E.Comparative immunogenicity of trivalent" exact="influenza" post="vaccine administered by intradermal or intramuscular route in healthy"/>
  <result pre="intramuscular route in healthy adultsVaccine2007256755676310.1016/j.vaccine.2007.06.06617692438 177.HuZ.JiaoX.LiuX.Antibody immunity induced by H7N9" exact="avian influenza" post="vaccines: Evaluation criteria, affecting factors, and implications for rational"/>
  <result pre="route in healthy adultsVaccine2007256755676310.1016/j.vaccine.2007.06.06617692438 177.HuZ.JiaoX.LiuX.Antibody immunity induced by H7N9 avian" exact="influenza" post="vaccines: Evaluation criteria, affecting factors, and implications for rational"/>
  <result pre="al.Preexisting influenza-specific CD4+ T cells correlate with disease protection against" exact="influenza" post="challenge in humansNat. Med.20121827428010.1038/nm.261222286307 179.ChengB.Y.Ortiz-RianoE.NogalesA.de la TorreJ.C.Martinez-SobridoL.Development of live-attenuated"/>
  <result pre="generating reassortant virus is based on the co-infection with two" exact="influenza" post="viruses in eggs. Both the WHO candidate IAV (left)"/>
 </snippets>
</snippetsTree>
